OCTA in neurodegenerative optic neuropathies: emerging biomarkers at the eye-brain interface

Samuel Asanad; Isa Mohammed; Alfredo A Sadun; Osamah J Saeedi

doi:10.1177/2515841420950508

OCTA in neurodegenerative optic neuropathies: emerging biomarkers at the eye-brain interface

Ther Adv Ophthalmol. 2020 Aug 27:12:2515841420950508. doi: 10.1177/2515841420950508. eCollection 2020 Jan-Dec.

Authors

Samuel Asanad¹, Isa Mohammed², Alfredo A Sadun³, Osamah J Saeedi²

Affiliations

¹ Department of Ophthalmology and Visual Sciences, University of Maryland Eye Associates, University of Maryland Medical Center and University of Maryland School of Medicine, 419 W. Redwood St., Baltimore, MD 21201, USA.
² Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
³ Doheny Eye Center, Los Angeles, CA, USA; Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Abstract

OCTA imaging in optic neuropathies.

Keywords: Alzheimer’s disease; Leber’s hereditary optic neuropathy; Parkinson’s disease; Wolfram Syndrome; dominant optic atrophy; erythrocyte mediated angiography; glaucoma; optic neuropathy; optical coherence tomography angiography; retinal blood flow; schizophrenia; vasomotion.

Publication types

Review